Skip to content

Investigation of the mechanism and materialbasis of Huopo Xialing decoction in improving the dysbiosis of oral and intestinal microbiota and halitosis based on the concept of "oral-gut microbiota interaction

Investigation of the mechanism and materialbasis of Huopo Xialing decoction in improving the dysbiosis of oral and intestinal microbiota and halitosis based on the concept of "oral-gut microbiota interaction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084581
Enrollment
Unknown
Registered
2024-05-21
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

halitosis

Interventions

Test group:The experimental group was given health education and treatment with Huopu Xialing decoction-free granules.
control group:The control group was given health education and treatment with triple live bifidobacteria.

Sponsors

The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 55 years old (including 18 and 55 years old); 2. Meet the above diagnostic criteria for halitosis, and the Rosenberg score is =2; 3. VSCs value >150ppb for sulfide detection instrument; 4. The area of tongue coating is =2, and the thickness of tongue coating is =2; 5. There is no habit of cleaning the tongue coating; 6. No history of smoking; 7. The course of the disease is = 15 days; 8. Volunteer and be able to participate in the experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Suffering from upper respiratory tract infection accompanied by oral infection and bad breath caused by hepatobiliary system, urinary system and other diseases; 2. Those with serious primary diseases such as heart, lung, liver, kidney and hematopoietic diseases; 3. Patients with malignant tumors; 4. Women are pregnant, lactating or preparing for pregnancy; 5. There is a mental disorder, which cannot cooperate with or does not cooperate with the treatment; 6. In the past three months, antibiotics, non-steroidal anti-inflammatory drugs, immunosuppressants, probiotics, and prebiotic preparations were used for oral treatment; 7. Have a history of allergies to the ingredients of experimental drugs;

Design outcomes

Primary

MeasureTime frame
Clinical effectiveness;

Secondary

MeasureTime frame
Volatile Sulfur Compounds, VSCs;Rosenberg rating;Traditional Chinese Medicine syndrome score;Microbial diversity analysis;Tongue coating area and thickness;Security indicators;

Countries

China

Contacts

Public ContactChen Shanshan

The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University

1028559014@qq.com+86 136 9816 0873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026